VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 544.6B
Enterprise Value 343.12B
Trailing P/E 169.07
Forward P/E 138.61
PEG Ratio (5 yr expected) 10.90
Price/Sales (ttm)17.92
Price/Book (mrq)21.93
Enterprise Value/Revenue 317.33
Enterprise Value/EBITDA 670.20

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 10.59%
Operating Margin (ttm)22.21%

Management Effectiveness

Return on Assets (ttm)10.73%
Return on Equity (ttm)5.42%

Income Statement

Revenue (ttm)2.49B
Revenue Per Share (ttm)10.00
Quarterly Revenue Growth (yoy)42.10%
Gross Profit (ttm)2.21B
EBITDA 614.23M
Net Income Avi to Common (ttm)263.19M
Diluted EPS (ttm)1.04
Quarterly Earnings Growth (yoy)205.60%

Balance Sheet

Total Cash (mrq)2.09B
Total Cash Per Share (mrq)8.23
Total Debt (mrq)606.43M
Total Debt/Equity (mrq)29.69
Current Ratio (mrq)3.28
Book Value Per Share (mrq)8.01

Cash Flow Statement

Operating Cash Flow (ttm)844.94M
Levered Free Cash Flow (ttm)550.57M

Trading Information

Stock Price History

Beta 1.95
52-Week Change 390.53%
S&P500 52-Week Change 315.75%
52 Week High 3178.15
52 Week Low 388.90
50-Day Moving Average 3165.28
200-Day Moving Average 3154.77

Share Statistics

Avg Vol (3 month) 31.77M
Avg Vol (10 day) 31.41M
Shares Outstanding 5253.89M
Float 253.26M
% Held by Insiders 10.51%
% Held by Institutions 197.44%
Shares Short 34.39M
Short Ratio 32.6
Short % of Float 31.77%
Shares Short (prior month) 33.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Aug 24, 2000